Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Home HIV test

This article was originally published in The Tan Sheet

Executive Summary

Home HIV test: Chiron predicts FDA approval "by the middle of this year" for Johnson & Johnson's Confide home HIV kit. "J&J plans to do a test launch in about four cities this year and then roll it out nationally in all markets in 1996," Chiron VP-Corporate Communications Larry Kurtz told attendees at the Alex. Brown healthcare seminar May 17 in Baltimore. Chiron and J&J's Direct Access Diagnostics entered an agreement last fall under which Chiron has an option to pay J&J $12 mil. during 1994 and 1995 in exchange for a 50-50 split of pre-tax profits generated by Confide...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083839

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel